BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bach JR. Medical considerations of long-term survival of Werdnig-Hoffmann disease. Am J Phys Med Rehabil 2007;86:349-55. [PMID: 17449979 DOI: 10.1097/PHM.0b013e31804b1d66] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 O'Connor G, Edel L, Raquq S, Bowerman M, Szmurlo A, Simpson Z, Hardy I, Fewtrell M, Baranello G. Open-labelled study to monitor the effect of an amino acid formula on symptom management in children with spinal muscular atrophy type I: The SMAAF pilot study. Nutr Clin Pract 2022. [PMID: 36504203 DOI: 10.1002/ncp.10940] [Reference Citation Analysis]
2 Panagiotou P, Kanaka-gantenbein C, Kaditis AG. Changes in Ventilatory Support Requirements of Spinal Muscular Atrophy (SMA) Patients Post Gene-Based Therapies. Children 2022;9:1207. [DOI: 10.3390/children9081207] [Reference Citation Analysis]
3 Rad N, Cai H, Weiss MD. Management of Spinal Muscular Atrophy in the Adult Population. Muscle Nerve 2022;65:498-507. [PMID: 35218574 DOI: 10.1002/mus.27519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Corsello A, Scatigno L, Pascuzzi MC, Calcaterra V, Dilillo D, Vizzuso S, Pelizzo G, Zoia E, Mandelli A, Govoni A, Bosetti A, Francavilla R, Indrio F, Fabiano V, Zuccotti GV, Verduci E. Nutritional, Gastrointestinal and Endo-Metabolic Challenges in the Management of Children with Spinal Muscular Atrophy Type 1. Nutrients 2021;13:2400. [PMID: 34371910 DOI: 10.3390/nu13072400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Yerushalmy-Feler A, Levy D, Sagi L, Fattal-Valevski A, Shiff YE, Brener A, Cohen S. Nutritional Therapy in Children With Spinal Muscular Atrophy in the Era of Nusinersen. J Pediatr Gastroenterol Nutr 2021;72:e154-60. [PMID: 33492038 DOI: 10.1097/MPG.0000000000003055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Singh NN, Hoffman S, Reddi PP, Singh RN. Spinal muscular atrophy: Broad disease spectrum and sex-specific phenotypes. Biochim Biophys Acta Mol Basis Dis 2021;1867:166063. [PMID: 33412266 DOI: 10.1016/j.bbadis.2020.166063] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
7 Ingram DG, Taylor JB, Partington MD, Imran S, Shellhaas RA. Sleep in Children with Myelomeningocele. Pediatric Sleep Medicine 2021. [DOI: 10.1007/978-3-030-65574-7_59] [Reference Citation Analysis]
8 Ropars J, Peudenier S, Genot A, Barnerias C, Espil C. Multidisciplinary approach and psychosocial management of spinal muscular atrophy (SMA). Archives de Pédiatrie 2020;27:7S45-9. [DOI: 10.1016/s0929-693x(20)30277-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Schorling DC, Pechmann A, Kirschner J. Advances in Treatment of Spinal Muscular Atrophy - New Phenotypes, New Challenges, New Implications for Care. J Neuromuscul Dis 2020;7:1-13. [PMID: 31707373 DOI: 10.3233/JND-190424] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 20.3] [Reference Citation Analysis]
10 Adami R, Bottai D. Spinal Muscular Atrophy Modeling and Treatment Advances by Induced Pluripotent Stem Cells Studies. Stem Cell Rev Rep 2019;15:795-813. [PMID: 31863335 DOI: 10.1007/s12015-019-09910-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
11 Mercuri E, Lucibello S, Perulli M, Coratti G, de Sanctis R, Pera MC, Pane M, Montes J, de Vivo DC, Darras BT, Kolb SJ, Finkel RS. Longitudinal natural history of type I spinal muscular atrophy: a critical review. Orphanet J Rare Dis 2020;15:84. [PMID: 32248834 DOI: 10.1186/s13023-020-01356-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
12 Stoimenis D, Spyridonidou C, Theofanidou S, Petridis N, Papaioannou N, Iasonidou C, Kapravelos N. Euglycemic Ketoacidosis in Spinal Muscular Atrophy. Case Rep Pediatr 2019;2019:2862916. [PMID: 30809411 DOI: 10.1155/2019/2862916] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Sheng L, Wan B, Feng P, Sun J, Rigo F, Bennett CF, Akerman M, Krainer AR, Hua Y. Downregulation of Survivin contributes to cell-cycle arrest during postnatal cardiac development in a severe spinal muscular atrophy mouse model. Hum Mol Genet 2018;27:486-98. [PMID: 29220503 DOI: 10.1093/hmg/ddx418] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
14 Pane M, Palermo C, Messina S, Sansone VA, Bruno C, Catteruccia M, Sframeli M, Albamonte E, Pedemonte M, D'Amico A, Brigati G, de Sanctis R, Coratti G, Lucibello S, Bertini E, Vita G, Danilo Tiziano F, Mercuri E; Italian EAP Working Group. An observational study of functional abilities in infants, children, and adults with type 1 SMA. Neurology 2018;91:e696-703. [PMID: 30045959 DOI: 10.1212/WNL.0000000000006050] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
15 Darras BT, Volpe JJ. Levels Above Lower Motor Neuron to Neuromuscular Junction. Volpe's Neurology of the Newborn 2018. [DOI: 10.1016/b978-0-323-42876-7.00032-6] [Reference Citation Analysis]
16 Deguise MO, Kothary R. New insights into SMA pathogenesis: immune dysfunction and neuroinflammation. Ann Clin Transl Neurol 2017;4:522-30. [PMID: 28695153 DOI: 10.1002/acn3.423] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
17 Wijngaarde CA, Blank AC, Stam M, Wadman RI, van den Berg LH, van der Pol WL. Cardiac pathology in spinal muscular atrophy: a systematic review. Orphanet J Rare Dis 2017;12:67. [PMID: 28399889 DOI: 10.1186/s13023-017-0613-5] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 8.3] [Reference Citation Analysis]
18 Kölbel H, Hauffa BP, Wudy SA, Bouikidis A, Della Marina A, Schara U. Hyperleptinemia in children with autosomal recessive spinal muscular atrophy type I-III. PLoS One 2017;12:e0173144. [PMID: 28278160 DOI: 10.1371/journal.pone.0173144] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
19 Szunyogova E, Zhou H, Maxwell GK, Powis RA, Muntoni F, Gillingwater TH, Parson SH. Survival Motor Neuron (SMN) protein is required for normal mouse liver development. Sci Rep 2016;6:34635. [PMID: 27698380 DOI: 10.1038/srep34635] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 6.6] [Reference Citation Analysis]
20 Miller N, Shi H, Zelikovich AS, Ma YC. Motor neuron mitochondrial dysfunction in spinal muscular atrophy. Hum Mol Genet 2016;25:3395-406. [PMID: 27488123 DOI: 10.1093/hmg/ddw262] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 10.6] [Reference Citation Analysis]
21 Simone C, Ramirez A, Bucchia M, Rinchetti P, Rideout H, Papadimitriou D, Re DB, Corti S. Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications? Cell Mol Life Sci 2016;73:1003-20. [PMID: 26681261 DOI: 10.1007/s00018-015-2106-9] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
22 Bogdanik LP, Osborne MA, Davis C, Martin WP, Austin A, Rigo F, Bennett CF, Lutz CM. Systemic, postsymptomatic antisense oligonucleotide rescues motor unit maturation delay in a new mouse model for type II/III spinal muscular atrophy. Proc Natl Acad Sci U S A 2015;112:E5863-72. [PMID: 26460027 DOI: 10.1073/pnas.1509758112] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 5.8] [Reference Citation Analysis]
23 Saquetto MB, Oliveira IK, B Ferreira J, Oliveira CP, Silva CM, Neto MG. Efeito e segurança da mobilização funcional em crianças com Síndrome de Werdnig-Hoffman. Rev Neurocienc 2015;23:451-456. [DOI: 10.4181/rnc.2015.23.03.1031.06p] [Reference Citation Analysis]
24 Gombash SE, Cowley CJ, Fitzgerald JA, Iyer CC, Fried D, McGovern VL, Williams KC, Burghes AH, Christofi FL, Gulbransen BD, Foust KD. SMN deficiency disrupts gastrointestinal and enteric nervous system function in mice. Hum Mol Genet 2015;24:3847-60. [PMID: 25859009 DOI: 10.1093/hmg/ddv127] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
25 Heier CR, Guerron AD, Korotcov A, Lin S, Gordish-Dressman H, Fricke S, Sze RW, Hoffman EP, Wang P, Nagaraju K. Non-invasive MRI and spectroscopy of mdx mice reveal temporal changes in dystrophic muscle imaging and in energy deficits. PLoS One 2014;9:e112477. [PMID: 25390038 DOI: 10.1371/journal.pone.0112477] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
26 Coque E, Raoul C, Bowerman M. ROCK inhibition as a therapy for spinal muscular atrophy: understanding the repercussions on multiple cellular targets. Front Neurosci 2014;8:271. [PMID: 25221469 DOI: 10.3389/fnins.2014.00271] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
27 Sproule D. Scoliosis. Encyclopedia of the Neurological Sciences 2014. [DOI: 10.1016/b978-0-12-385157-4.00643-6] [Reference Citation Analysis]
28 Porensky PN, Burghes AH. Antisense oligonucleotides for the treatment of spinal muscular atrophy. Hum Gene Ther 2013;24:489-98. [PMID: 23544870 DOI: 10.1089/hum.2012.225] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 6.3] [Reference Citation Analysis]
29 Rudnik-schöneborn S, Lorson C, Shababi M. Infantile spinale Muskelatrophie: mehr als eine Motoneuronerkrankung? Medizinische Genetik 2013;25:347-51. [DOI: 10.1007/s11825-013-0398-4] [Reference Citation Analysis]
30 Shababi M, Lorson CL, Rudnik-Schöneborn SS. Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease? J Anat 2014;224:15-28. [PMID: 23876144 DOI: 10.1111/joa.12083] [Cited by in Crossref: 140] [Cited by in F6Publishing: 156] [Article Influence: 14.0] [Reference Citation Analysis]
31 Rudnik-schöneborn S, Zerres K. Spinal Muscular Atrophies. Emery and Rimoin's Principles and Practice of Medical Genetics 2013. [DOI: 10.1016/b978-0-12-383834-6.00137-3] [Reference Citation Analysis]
32 Biondi O, Lopes P, Desseille C, Branchu J, Chali F, Ben Salah A, Pariset C, Chanoine C, Charbonnier F. Physical exercise reduces cardiac defects in type 2 spinal muscular atrophy-like mice. J Physiol 2012;590:5907-25. [PMID: 22930275 DOI: 10.1113/jphysiol.2012.238196] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
33 Osborne M, Gomez D, Feng Z, McEwen C, Beltran J, Cirillo K, El-Khodor B, Lin MY, Li Y, Knowlton WM, McKemy DD, Bogdanik L, Butts-Dehm K, Martens K, Davis C, Doty R, Wardwell K, Ghavami A, Kobayashi D, Ko CP, Ramboz S, Lutz C. Characterization of behavioral and neuromuscular junction phenotypes in a novel allelic series of SMA mouse models. Hum Mol Genet 2012;21:4431-47. [PMID: 22802075 DOI: 10.1093/hmg/dds285] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
34 David BE, Weitzman GA, Hervé C, Fellous M. Genetic counseling for the orthodox jewish couple undergoing preimplantation genetic diagnosis. J Genet Couns 2012;21:625-30. [PMID: 22532276 DOI: 10.1007/s10897-012-9502-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
35 Grigg-damberger MM. Sleep and Sleep Problems in Children with Neurologic Disorders. Therapy in Sleep Medicine 2012. [DOI: 10.1016/b978-1-4377-1703-7.10040-4] [Reference Citation Analysis]
36 Porensky PN, Mitrpant C, McGovern VL, Bevan AK, Foust KD, Kaspar BK, Wilton SD, Burghes AH. A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse. Hum Mol Genet 2012;21:1625-38. [PMID: 22186025 DOI: 10.1093/hmg/ddr600] [Cited by in Crossref: 188] [Cited by in F6Publishing: 198] [Article Influence: 15.7] [Reference Citation Analysis]
37 Sproule DM, Kaufmann P. Therapeutic developments in spinal muscular atrophy. Ther Adv Neurol Disord 2010;3:173-85. [PMID: 21179609 DOI: 10.1177/1756285610369026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
38 Sleigh JN, Gillingwater TH, Talbot K. The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy. Dis Model Mech 2011;4:457-67. [PMID: 21708901 DOI: 10.1242/dmm.007245] [Cited by in Crossref: 97] [Cited by in F6Publishing: 102] [Article Influence: 8.1] [Reference Citation Analysis]
39 Passini MA, Bu J, Richards AM, Kinnecom C, Sardi SP, Stanek LM, Hua Y, Rigo F, Matson J, Hung G, Kaye EM, Shihabuddin LS, Krainer AR, Bennett CF, Cheng SH. Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy. Sci Transl Med 2011;3:72ra18. [PMID: 21368223 DOI: 10.1126/scitranslmed.3001777] [Cited by in Crossref: 355] [Cited by in F6Publishing: 376] [Article Influence: 29.6] [Reference Citation Analysis]
40 Heier CR, Satta R, Lutz C, DiDonato CJ. Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice. Hum Mol Genet 2010;19:3906-18. [PMID: 20693262 DOI: 10.1093/hmg/ddq330] [Cited by in Crossref: 128] [Cited by in F6Publishing: 138] [Article Influence: 9.8] [Reference Citation Analysis]
41 Bevan AK, Hutchinson KR, Foust KD, Braun L, McGovern VL, Schmelzer L, Ward JG, Petruska JC, Lucchesi PA, Burghes AH, Kaspar BK. Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery. Hum Mol Genet 2010;19:3895-905. [PMID: 20639395 DOI: 10.1093/hmg/ddq300] [Cited by in Crossref: 155] [Cited by in F6Publishing: 165] [Article Influence: 11.9] [Reference Citation Analysis]
42 Araujo Ap, Araujo M, Swoboda KJ. Vascular perfusion abnormalities in infants with spinal muscular atrophy. J Pediatr 2009;155:292-4. [PMID: 19619755 DOI: 10.1016/j.jpeds.2009.01.071] [Cited by in Crossref: 96] [Cited by in F6Publishing: 102] [Article Influence: 6.9] [Reference Citation Analysis]